APODX | LIFCX | APODX / LIFCX | |
Total Expense Ratio | 0.45 | 1.40 | 32% |
Annual Report Gross Expense Ratio | 0.45 | 1.40 | 32% |
Fund Existence | 12 years | 14 years | - |
Gain YTD | 3.502 | 3.044 | 115% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.53B | 759M | 202% |
Annual Yield % from dividends | 2.45 | 3.96 | 62% |
Returns for 1 year | 6.34 | 5.60 | 113% |
Returns for 3 years | 9.77 | 9.34 | 105% |
Returns for 5 years | 19.70 | 30.83 | 64% |
Returns for 10 years | 31.14 | 25.24 | 123% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CVQZX | 8.66 | -0.10 | -1.14% |
Columbia Disciplined Value Inst | |||
VNSCX | 19.19 | -0.28 | -1.44% |
Natixis Vaughan Nelson Select C | |||
TILPX | 28.79 | -0.43 | -1.47% |
Nuveen Large Cap Growth Premier | |||
HEQFX | 4.63 | -0.07 | -1.49% |
Monteagle Opportunity Equity Inv | |||
BMSRX | 14.02 | -0.23 | -1.61% |
MFS Blended Research Mid Cap Eq R1 |